Right ventricular outflow tract (RVOT) obstruction with hypertrophic cardiomyopathy (HCM) would favour a diagnosis of:
a) Danon disease
b) Anderson-Fabry disease
c) Noonan syndrome
d) Pompe disease
Dynamic left ventricular outflow tract (LVOT) obstruction can occur in:
a) Hypertrophic cardiomyopathy
b) Calcification of posterior mitral annulus
c) Hypovolemia
d) All of the above
Coved ST segment elevation in lateral leads in hypertrophic cardiomyopathy (HCM) is suggestive of:
a) Lateral wall myocardial infarction
b) Apical aneurysm
c) Coronary vasospasm
d) None of the above
North West (extreme superior) QRS axis in hypertrophic cardiomyopathy (HCM) is most likely due to:
a) Fabry disease
b) Noonan syndrome
c) Danon disease
d) None of the above
Non-HDL cholesterol is defined as the difference between total cholesterol level and HDL cholesterol level. Non-HDL cholesterol includes several lipoproteins.
Diagnosis of hypertrophic cardiomyopathy (HCM) in a first degree relative by European Society of Cardiology 2014 guideline needs left ventricular wall thickness of:
a) 15 millimeters or more
b) 14
Echocardiography is useful in demonstrating right heart thrombi, features of right ventricular overload and dysfunction as well as in differential diagnosis of acute pulmonary embolism.
Strongest risk predictor in hypertrophic cardiomyopathy:
a) History of sudden cardiac death in multiple family members
b) Previous cardiac arrest or sustained ventricular arrhythmia
c) Septal thickness more than 30 millimeters
d)
Pulmonary thromboendarterectomy is the treatment of choice for:
a) Primary pulmonary hypertension
b) Eisenmenger syndrome
c) Chronic thromboembolic pulmonary hypertension (CTEPH)
d) Massive pulmonary embolism